story of the week
ERSPC: Screening and Prostate Cancer Mortality
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Screening and Prostate Cancer Mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 Years of Follow-up
Lancet 2014 Aug 07;[EPub Ahead of Print], FH Schröder, J Hugosson, MJ Roobol, TL Tammela, M Zappa, V Nelen, M Kwiatkowski, M Lujan, L Määttänen, H Lilja, LJ Denis, F Recker, A Paez, CH Bangma, S Carlsson, D Puliti, A Villers, X Rebillard, M Hakama, UH Stenman, P Kujala, K Taari, G Aus, A Huber, TH van der Kwast, RH van Schaik, HJ de Koning, SM Moss, A AuvinenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.